LEUKOTRIENE D4 OPTIONS

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of such mitotic motors was arrested only after they were being separately inhibited, lending guidance towards the proposal that a mixture drug therapy targeting these motors may be a workable approach for beating chemotherapeuti